[{"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":86635000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":86690000.0,"CommonStockSharesConverted_0_Q3_shares":106282000.0,"Assets_0_Q3_USD":2047407000.0,"RevenuesConverted_3_Q3_USD":1985717000.0,"RevenuesConverted_1_Q3_USD":721789000.0,"NetIncomeLossConverted_3_Q3_USD":407173000.0,"StockholdersEquity_0_Q3_USD":440576000.0,"CommonStockSharesOutstanding_0_Q3_shares":85300000.0,"EarningsPerShareDiluted_3_Q3_USD":4.7,"EarningsPerShareDiluted_1_Q3_USD":1.69,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":429129000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":85293000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":85314000.0,"StockholdersEquityConverted_0_Q3_USD":441115000.0,"NetIncomeLossConverted_1_Q3_USD":146219000.0,"EarningsPerShareBasic_1_Q3_USD":1.71,"EarningsPerShareBasic_3_Q3_USD":4.77,"Ticker":"IDXX","CIK":"874716","name":"IDEXX LABORATORIES INC \/DE","OfficialName":"IDEXX Laboratories Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"42180715521.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"SP500","filed":"20201029"}]